Diclofenac Patch — Membership Pricing

Other medications in Pain & Inflammation

• Diflunisal
• Dihydroergotamine
• Eletriptan
• Ergotamine
• Etodolac
• Fenoprofen
• Flurbiprofen
• Frovatriptan

About Diclofenac Patch

The diclofenac patch offers a targeted approach to managing localized pain, providing direct relief where it's needed most. Whether you're dealing with a sprain or chronic joint discomfort, this convenient treatment can be a game-changer. As a member of TheDrugClub, you don't have to let high prescription costs stand in the way of your well-being. Discover how this pain solution works and how your membership helps you save.

What Does the Diclofenac Patch Treat?

The diclofenac patch is a topical nonsteroidal anti-inflammatory drug (NSAID) primarily used to relieve localized pain associated with acute strains, sprains, bruises, and osteoarthritis. It's particularly effective for pain in specific joints like the knee, ankle, elbow, or wrist. Unlike oral NSAIDs that circulate throughout your entire body, the patch delivers medication directly through the skin to the affected area, making it a popular choice for those seeking targeted relief with potentially fewer systemic side effects.

How Does It Work?

Diclofenac works by inhibiting certain enzymes in the body that are responsible for producing prostaglandins, chemicals that cause inflammation, pain, and fever. When applied as a patch, diclofenac is absorbed through the skin into the underlying tissues, concentrating its anti-inflammatory and analgesic effects directly at the source of the pain. This localized delivery helps to reduce swelling, stiffness, and pain, allowing for improved movement and comfort. The slow, sustained release of medication from the patch ensures continuous therapeutic levels in the affected area over its wear time.

Understanding Typical Costs

The cost of diclofenac patches can vary significantly depending on several factors, including whether you purchase the brand-name version (e.g., Flector Patch) or a generic

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Diclofenac Patch is approved for (FDA label)

1. ​INDICATIONS & USAGE Xiclo™ Transdermal Patch is indicated in adults over the age of 12 years old for the treatment of signs and symptoms of osteoarthritis of the joints, and of acute and chronic pain in muscles and joints associated with muscle soreness, strains, sprains, arthritis, simple backache, muscle stiffness, and more.

Source: Read the full FDA label on DailyMed. Label effective date: December 18, 2025.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Dosage forms and strengths for Diclofenac Patch (FDA label)

Xiclo™ Transdermal Patch contains 1.25% diclofenac. Each patch is 2 in x 4 in (5.08 cm x 10.16 cm) and consists of an adhesive side containing active/inactive ingredients and an outer surface backing layer. The adhesive side is covered with a removable, clear, plastic film. The outer surface of the backing layer is imprinted with the Xiclo™ Transdermal Patch logo.

Source: FDA prescribing information (DailyMed). Set ID: 2d93a01c-40a9-8fb0-e063-6394a90a2cc6. SPL document ID: 463f4bb7-e16f-4966-e063-6294a90a58eb. Label effective date: December 18, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Diclofenac Patch (FDA label)

Xiclo™ Transdermal Patch is contraindicated in patients with a known history of hypersensitivity to non-steroidal anti-inflammatory medications such as diclofenac. Diclofenac is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. History of asthma, uticaria, or allergic-type reactions after absorbing non-steroidal anti-inflammatory drugs (NSAIDs) should also be considered.

Source: FDA prescribing information (DailyMed). Set ID: 2d93a01c-40a9-8fb0-e063-6394a90a2cc6. SPL document ID: 463f4bb7-e16f-4966-e063-6294a90a58eb. Label effective date: December 18, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Warnings and precautions for Diclofenac Patch (FDA label)

5. WARNINGS, PRECAUTIONS & ADVERSE REACTIONS 5.1 Risk of Serious Cardiovascular and Gastrointestinal Events Nonsteroidal anti-inflammatory drugs (NSAIDs) can cause an increased risk of serious cardiovascular (CV) thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use. NSAIDs, including diclofenac, can lead to new onset of hypertension, or worsening of preexisting hypertension, either of which may contribute to the increased incidence of CV events. To minimize the potential risk for an adverse CV event in NSAID-treated patients, use the lowest effective dose for the shortest duration possible. Avoid the use of diclofenac external in patients with a recent MI unless the benefits are expected to outweigh the risk of recurrent CV thrombotic events. If diclofenac external is used in patients with a recent MI, monitor patients for signs of cardiac ischemia.

Source: FDA prescribing information (DailyMed). Set ID: 2d93a01c-40a9-8fb0-e063-6394a90a2cc6. SPL document ID: 463f4bb7-e16f-4966-e063-6294a90a58eb. Label effective date: December 18, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Diclofenac Patch (FDA label)

Drugs That Interfere with Hemostasis Monitor patients with concomitant use of diclofenac external with anticoagulants (e.g., warfarin), antiplatelet agents (e.g., aspirin), selective serotonin reuptake inhibitors (SSRIs), and serotonin norepinephrine reuptake inhibitors (SNRIs) for signs of bleeding. Aspirin Concomitant use of diclofenac external and analgesic doses of aspirin is not generally recommended because of the increased risk of bleeding. ACE Inhibitors, Angiotensin Receptor Blockers, and Beta-Blockers When these drugs are administered concomitantly, patients should be adequately hydrated. Assess renal function at the beginning of the concomitant treatment. Diuretics During concomitant use of diclofenac external with diuretics, observe patients for signs of worsening renal function, in addition to assuring diuretic efficacy including antihypertensive effects. Digoxin During concomitant use of diclofenac external and digoxin, monitor serum digoxin levels. Lithium During concomitant use of diclofenac external and lithium, monitor patients for signs of lithium toxicity.

Source: FDA prescribing information (DailyMed). Set ID: 2d93a01c-40a9-8fb0-e063-6394a90a2cc6. SPL document ID: 463f4bb7-e16f-4966-e063-6294a90a58eb. Label effective date: December 18, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.